Imviva Biotech Granted FDA IDE Authorization for Cancer Treatment Trial
By Karen Roman Imviva Biotech said it has FDA authorization for its Investigational Device Exemption application to use Adaptive Biotechnologies’ clonoSEQ assay in the TENACITY-01...
